Call 2-1-1 for local resources · Life-threatening emergencies: 9-1-1
Back to education guides

Substance education guide

Tapentadol (Nucynta)

Atypical Schedule II analgesic · Mu-opioid agonist · Norepinephrine reuptake inhibitor

· How it works

Classification and dual mechanism

Tapentadol combines mu-opioid receptor agonism with norepinephrine reuptake inhibition. Unlike tramadol, it has little clinically meaningful serotonin reuptake activity and does not depend on an active metabolite for analgesia.

· Immediate effects

Recognize the effects

Signs of Use

  • Analgesia, relaxation, dizziness, nausea, and drowsiness
  • Euphoria, mental clouding, sweating, and dry mouth
  • Pinpoint pupils, palpitations, tachycardia, or hypotension
  • Confusion, delirium, or seizure activity
  • Slow, shallow, gurgling, or absent breathing

Short Term

  • Therapeutic exposure: pain relief, dizziness, nausea, and sedation
  • High exposure: euphoria, heavy sedation, sweating, miosis, and palpitations
  • Severe toxicity: respiratory depression, hypotension, confusion, and seizures
  • Extended-release dose dumping can cause abrupt systemic toxicity
  • Alcohol and sedatives greatly increase hypoventilation risk

Long Term

  • Physical dependence on opioid and norepinephrine pathways
  • Mixed opioid and SNRI-like withdrawal with anxiety, insomnia, and brain zaps
  • Cognitive slowing, impaired reaction time, and accidents
  • Opioid use disorder and escalating misuse

· Long-term consequences

Opioid overdose with cardiovascular instability

Call 911, administer naloxone, provide rescue breathing, and monitor continuously for recurrent respiratory depression, hypotension, tachycardia, or seizures.

Back to education guides